+91 9891296838 / 9811747774
CIMZIA is a tumor necrosis factor (TNF) blocker indicated for (1) Reducing signs and symptoms of Crohn’s disease and maintaining clinical (2) response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy (3) Treatment of adults with moderately to severely active rheumatoid arthritis (4) Treatment of adult patients with active psoriatic arthritis. (5) Treatment of adults with active ankylosing spondylitis.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Cimzia (Certolizumab Pegol) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the CIMZIA (certolizumab pegol) medicine cost price in India.
The order for Cimzia (Certolizumab Pegol) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB.
CIMZIA (certolizumab pegol) for injection, for subcutaneous use.
CIMZIA (certolizumab pegol) injection, for subcutaneous use. Initial U.S. Approval: 2008
Generic Name: Certolizumab Pegol
For injection: 200 mg lyophilized powder for reconstitution in a single use vial, with 1 mL of sterile Water for Injection
Injection: 200 mg/mL solution in a single-use prefilled syringe
GET IN TOUCH
with Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Cimzia (Certolizumab Pegol) on prescription and Import License in Patient's Name only.
For overseas patients, Cimzia (Certolizumab Pegol) can be made available in Send your enquiry to find Cimzia (Certolizumab Pegol) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
FDA approves treatment for patients with a type of inflammatory arthritis For More Details
FDA Approves Abrilada, Biosimilar to Humira, for Adults with Ankylosing Spondylitis and Other Disorders For More Details